Cannabis and Mental Health

The relationship between cannabis and mental health is one of the most intensively researched areas of cannabis science. The evidence is complex: cannabis is perceived as relaxing and anxiolytic by many users, but can carry substantial mental health risks for specific population groups.

## Anxiety and Panic – THC's Dual Role

Cannabis shows a pronounced bidirectional effect regarding anxiety: in low doses THC can be anxiolytic; in higher doses it can trigger or worsen anxiety and panic. High THC doses activate the amygdala – the brain region responsible for processing fear and threat perception – producing states resembling panic attacks: rapid heartbeat, chest tightness, feeling of losing control, and irrational beliefs about one's safety or health. These reactions occur more frequently in beginners, people with existing anxiety disorders, when consuming high-potency cannabis (THC > 20%), and in uncomfortable settings.

Scientific evidence shows that using cannabis to self-medicate anxiety is counterproductive long-term: regular use can increase anxiety sensitivity, and rebound anxiety effects can occur between consumption periods.

## Depression – Short-Term Relief, Long-Term Risks

Cannabis can temporarily alleviate depressive mood by activating the reward system, but long-term regular use is associated with higher prevalence of depressive disorders. The causality question is complex – bidirectional relationships are evidenced. Mechanistically, chronic cannabis use may desensitize the dopamine system, reducing reward responses to normally pleasurable activities (anhedonia – a core symptom of depression).

## Psychosis Risk – A Serious Warning

Multiple large epidemiological studies consistently show: regular cannabis use increases psychosis risk (particularly schizophrenia-spectrum disorders) by 1.5 to 3-fold compared to non-users. High-potency cannabis (THC > 10–15%) carries greater risk. The association is dose-dependent – earlier onset, higher frequency, and higher THC content all increase risk. Genetic factors (COMT and AKT1 gene variants) influence individual vulnerability.

Anyone with a personal or family history of psychosis, schizophrenia, bipolar disorder, or other serious psychiatric conditions should avoid cannabis entirely.

## Adolescents and the Developing Brain

The human brain develops until approximately age 25, with the endocannabinoid system playing a central role in developing brain structures. Studies in adolescents with early-onset regular use show reduced hippocampal and prefrontal cortex volume, impaired working memory and executive functions, increased risk of school failure, and dramatically elevated dependency risk compared to those who start as adults.

## Dependency – The 9% Phenomenon

Approximately 9% of people who have ever used cannabis develop a cannabis use disorder. Among daily users, this rises to 25–50%. Risk is significantly elevated for those who began using in adolescence. Cannabis withdrawal syndrome (officially recognized in DSM-5) produces sleep disturbances, irritability, anxiety, reduced appetite, mood dips, sweating, and headaches – typically starting 24–72 hours after last use and lasting 1–2 weeks.

## Counseling and Help

BZgA counseling hotline: 0800 2 31 23 17 (free, anonymous). Cannabis Social Clubs are legally required to have an addiction prevention officer available as a first point of contact. Local addiction counseling centers (Caritas, Diakonie, AWO) offer free support in all German cities. Seeking help is not a sign of weakness – cannabis use disorder is a recognized, treatable condition.